DiaMedica to Present at LD Micro Invitational
(firmenpresse) - MINNEAPOLIS, MINNESOTA -- (Marketwired) -- 05/27/15 -- DiaMedica Inc. (TSX VENTURE: DMA), announced that Mr. Rick Pauls, President and Chief Executive Officer, will make an overview presentation of the Company''s strategic direction at the LD Micro Conference on Monday, June 1, 2015 at 10:30AM PDT / 1:30PM EDT at the Luxe Hotel in Los Angeles, California. Mr. Pauls will also be available to participate in one-on-one meetings, made by appointment, with investors who are registered to attend the conference.
About LD Micro
LD Micro is an investment newsletter firm that focuses on finding undervalued companies in the micro-cap space. Since 2002, the firm has published reports on select companies throughout the year. The firm also hosts the LD Micro Main Event in December. It is a non-registered investment advisor. For more information, please contact 408-457-1042 or visit .
About DiaMedica
DiaMedica is a publicly traded (TSX VENTURE: DMA) biopharmaceutical company focused on large unmet diseases including novel approaches to treat vascular and metabolic diseases. DiaMedica''s lead product, DM199, is recombinant human tissue kallikrein-1 protein (rhKLK1) for the treatment of acute ischemic stroke and kidney disease. DiaMedica''s common shares are listed on the TSX Venture Exchange in Canada under the trading symbol ''DMA''.
FORWARD-LOOKING STATEMENTS
The statements made in this press release that are not historical facts contain forward-looking information that involves risk and uncertainties. All statements, other than statements of historical facts, which address DiaMedica''s expectations, should be considered forward-looking statements. Such statements are based on management''s exercise of business judgment as well as assumptions made by and information currently available to management. When used in this document, the words "may", "will", "anticipate", "believe", "estimate", "expect", "intend" and words of similar import, are intended to identify any forward-looking statements. You should not place undue reliance on these forward-looking statements. These statements reflect a current view of future events and are subject to certain risks and uncertainties as contained in the Company''s filings with Canadian securities regulatory authorities. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results could differ materially from those anticipated in these forward-looking statements. The Company undertakes no obligation, and does not intend, to update, revise or otherwise publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof, or to reflect the occurrence of any unanticipated events. Although management believes that expectations are based on reasonable assumptions, no assurance can be given that these expectations will materialize.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the contents of this News Release.
Contacts:
DiaMedica Inc.
Rick Pauls
President and CEO
763-710-4455
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 27.05.2015 - 06:00 Uhr
Sprache: Deutsch
News-ID 1361509
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
MINNEAPOLIS, MINNESOTA
Phone:
Kategorie:
Hospitals, Facilities and Providers
Anmerkungen:
Diese Pressemitteilung wurde bisher 139 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DiaMedica to Present at LD Micro Invitational
"
steht unter der journalistisch-redaktionellen Verantwortung von
DiaMedica Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
